Aethlon Medical, Inc.

  • Home
  • The Hemopurifier®
    • The Hemopurifier® in Infectious Disease
    • The Hemopurifier® in Cancer
    • Resources
  • About
    • Overview
    • Executive Team
    • Board of Directors
    • Contact Us
  • News & Media
    • Press Releases
    • Presentations
    • Events
    • Outside Media
    • Training Videos
  • Investors
    • Overview
    • Corporate News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
    • IRS Form 8937
News & Media

News & Media

  • Press Releases
  • Presentations
  • Events
  • Outside Media
  • Training Videos

Press Releases

Nov 9, 2017

Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors

Nov 2, 2017

Aethlon Medical Announces Fiscal 2018 Second Quarter Results

Oct 30, 2017

Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017

Oct 16, 2017

Aethlon Medical Announces Large-Scale Production Collaboration

Oct 11, 2017

Aethlon Medical to Present at the 2017 BIO Investor Forum

Oct 10, 2017

Aethlon Medical Announces Compliance With Nasdaq Listing Criteria

Oct 2, 2017

Aethlon Medical Announces Pricing of $6 Million Public Offering

Sep 14, 2017

Aethlon Medical Receives National Cancer Institute Contract Award

Sep 12, 2017

Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses

Sep 6, 2017

Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017

    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • ...21
    • Twitter
    • Linkedin
    • YouTube
    Privacy Policy Disclaimer Sitemap
    © 2023 Aethlon Medical, Inc. All Rights Reserved.